DiscoverThe Crux of Medtech“AI is not Taking the Lead, AI is the Enabler” - With David Caumartin
“AI is not Taking the Lead, AI is the Enabler” - With David Caumartin

“AI is not Taking the Lead, AI is the Enabler” - With David Caumartin

Update: 2025-05-21
Share

Description

Join your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures. 

During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago. 

He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography. 

David goes on to discuss the benefits of AI in the surgical space, suggesting that it can improve surgeons’ accuracy, patient outcomes and medical research. 

He also touched on RebrAIn’s clinical trials and the findings that are emerging from them. 

Key Topics: 

  • David’s transition from GE to startup

  • RebrAIn’s unique AI technology 

  • The challenges and opportunities within the US market

  • The impact of AI on healthcare

Related Insights: 

  • AI is making healthcare smarter, faster, and more efficient 

  • Collaboration is the key to progress in the healthcare field 

  • RebrAIn’s technology can create accurate targets from 100 cases rather than 20,000

Core Challenges:

  • The brain is one of the most delicate parts of human anatomy. In order to successfully operate on it, surgeons have to be as precise as possible. Factors like hand tremors, indecision or human error can have a huge impact on patient outcomes.  

  • With an AI assistant, surgeons can assess the best course of action more quickly and accurately. RebrAIn’s AI tool serves as another neurosurgeon in the room. 

Tune in now to discover the future of neurosurgery.


The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.


To learn more about Cruxx,⁠⁠⁠⁠⁠⁠ ⁠click here.⁠⁠⁠⁠⁠⁠


A big thank you to our sponsors on this season of the podcast;


⁠⁠⁠⁠⁠TTP plc⁠⁠⁠⁠⁠⁠⁠ With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, ⁠⁠⁠⁠⁠⁠⁠TTP plc⁠⁠⁠⁠⁠⁠⁠ can accelerate your development with the latest technologies. Learn more at ⁠⁠⁠⁠⁠⁠⁠TTP.com⁠⁠⁠⁠⁠⁠⁠


&


⁠KUKA⁠ is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.


KUKA provides trusted support throughout the product life cycle, from development to integration and beyond. 

Find out more at ⁠⁠⁠⁠⁠kuka.com/healthcare

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

“AI is not Taking the Lead, AI is the Enabler” - With David Caumartin

“AI is not Taking the Lead, AI is the Enabler” - With David Caumartin

The Crux of Medtech